The outlook for HIV drug development

The outlook for HIV drug development Moritz Herrmann

The HIV market is shifting towards integrase inhibitor-based single-tablet regimens – but emerging markets such as Brazil and China are hesitant to pay the cost.Since the first anti-HIV drug Retrovir... Read more

7 Questions: Vincent Varlet on digital technology for health

7 Questions: Vincent Varlet on digital technology for healthVincent Varlet

pharmaphorum spoke to the executive director for marketing and communication at Novartis Pharma in France about his views on digital healthcare and technology.What is your involvement in digital healthcare/healthcare technology?I... Read more

Tapping Latin America’s healthcare market

Tapping Latin America’s healthcare marketGuillaume Corpart

Guillaume Corpart outlines the current and future health environment in the region, pinpointing the markets ripe for development in this first of a two-part series.A decade of prosperity in Latin... Read more

Early access initiatives – one year on

Early access initiatives – one year onLeela Barham

Both the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) launched new initiatives aimed at achieving earlier access to promising new medicines a year... Read more